Manufacturing - Tools & Accessories
Build Your Comparison
Side-by-side financial analysisStock Comparison
EML vs ASTE vs JPM vs BAC vs CMI
Revenue, margins, valuation, and 5-year total return — side by side.
Agricultural - Machinery
Banks - Diversified
Banks - Diversified
Industrial - Machinery
EML vs ASTE vs JPM vs BAC vs CMI — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Manufacturing - Tools & Accessories | Agricultural - Machinery | Banks - Diversified | Banks - Diversified | Industrial - Machinery |
| Market Cap | $131M | $1.18B | $896.00B | $422.78B | $91.13B |
| Revenue (TTM) | $243M | $1.48B | $280.33B | $191.57B | $33.89B |
| Net Income (TTM) | $4M | $26M | $57.05B | $30.51B | $2.67B |
| Gross Margin | 21.7% | 26.1% | 60.0% | 56.1% | 25.4% |
| Operating Margin | 3.0% | 3.7% | 25.9% | 19.7% | 11.2% |
| Forward P/E | 11.0x | 14.3x | 14.4x | 12.6x | 22.7x |
| Total Debt | $54M | $320M | $942.38B | $365.90B | $8.11B |
| Cash & Equiv. | $7M | $72M | $343.34B | $231.84B | $2.85B |
EML vs ASTE vs JPM vs BAC vs CMI — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jun 20 | Jun 26 | Return |
|---|---|---|---|
| The Eastern Company (EML) | 100 | 121.7 | +21.7% |
| Astec Industries, I… (ASTE) | 100 | 110.9 | +10.9% |
| JPMorgan Chase & Co. (JPM) | 100 | 341.0 | +241.0% |
| Bank of America Cor… (BAC) | 100 | 235.9 | +135.9% |
| Cummins Inc. (CMI) | 100 | 380.7 | +280.7% |
Price return only. Dividends and distributions are not included.
Quick Verdict: EML vs ASTE vs JPM vs BAC vs CMI
Each card shows where this stock fits in a portfolio — not just who wins on paper.
EML ranks third and is worth considering specifically for sleep-well-at-night and defensive.
- Lower volatility, beta 0.66, Low D/E 43.2%, current ratio 3.59x
- Beta 0.66, yield 2.0%, current ratio 3.59x
- Beta 0.66 vs CMI's 1.64, lower leverage
ASTE is the clearest fit if your priority is growth exposure.
- Rev growth 8.1%, EPS growth 7.8%, 3Y rev CAGR 3.4%
- 8.1% revenue growth vs EML's -8.7%
JPM has the current edge in this matchup, primarily because of its strength in valuation efficiency and bank quality.
- PEG 0.81 vs CMI's 2.01
- NIM 2.2% vs BAC's 1.8%
- Lower P/E (14.4x vs 22.7x), PEG 0.81 vs 2.01
- 20.4% margin vs EML's 1.6%
BAC is the clearest fit if your priority is income & stability.
- Dividend streak 12 yrs, beta 0.86, yield 2.3%
- 2.3% yield, 12-year raise streak, vs CMI's 1.2%
CMI is the #2 pick in this set and the best alternative if long-term compounding is your priority.
- 5.3% 10Y total return vs JPM's 465.8%
- +105.6% vs EML's -6.1%
- 7.8% ROA vs BAC's 0.9%, ROIC 16.1% vs 3.5%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 8.1% revenue growth vs EML's -8.7% | |
| Value | Lower P/E (14.4x vs 22.7x), PEG 0.81 vs 2.01 | |
| Quality / Margins | 20.4% margin vs EML's 1.6% | |
| Stability / Safety | Beta 0.66 vs CMI's 1.64, lower leverage | |
| Dividends | 2.3% yield, 12-year raise streak, vs CMI's 1.2% | |
| Momentum (1Y) | +105.6% vs EML's -6.1% | |
| Efficiency (ROA) | 7.8% ROA vs BAC's 0.9%, ROIC 16.1% vs 3.5% |
EML vs ASTE vs JPM vs BAC vs CMI — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
EML vs ASTE vs JPM vs BAC vs CMI — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
CMI leads in 2 of 6 categories
JPM leads 1 • EML leads 1 • ASTE leads 0 • BAC leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
JPM leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
JPM is the larger business by revenue, generating $280.3B annually — 1155.0x EML's $243M. JPM is the more profitable business, keeping 20.4% of every revenue dollar as net income compared to EML's 1.6%. On growth, ASTE holds the edge at +20.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $243M | $1.5B | $280.3B | $191.6B | $33.9B |
| EBITDAEarnings before interest/tax | $12M | $84M | $81.4B | $40.0B | $4.6B |
| Net IncomeAfter-tax profit | $4M | $26M | $57.0B | $30.5B | $2.7B |
| Free Cash FlowCash after capex | $10M | $37M | $100.9B | $12.6B | $2.7B |
| Gross MarginGross profit ÷ Revenue | +21.7% | +26.1% | +60.0% | +56.1% | +25.4% |
| Operating MarginEBIT ÷ Revenue | +3.0% | +3.7% | +25.9% | +19.7% | +11.2% |
| Net MarginNet income ÷ Revenue | +1.6% | +1.7% | +20.4% | +15.9% | +7.9% |
| FCF MarginFCF ÷ Revenue | +4.0% | +2.5% | +36.0% | +6.6% | +7.9% |
| Rev. Growth (YoY)Latest quarter vs prior year | -5.7% | +20.3% | — | — | +2.7% |
| EPS Growth (YoY)Latest quarter vs prior year | -65.6% | -90.3% | +16.0% | +18.3% | -21.0% |
Valuation Metrics
EML leads this category, winning 4 of 7 comparable metrics.
Valuation Metrics
At 14.7x trailing earnings, BAC trades at a 54% valuation discount to CMI's 32.2x P/E. Adjusting for growth (PEG ratio), JPM offers better value at 0.90x vs CMI's 2.85x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $131M | $1.2B | $896.0B | $422.8B | $91.1B |
| Enterprise ValueMkt cap + debt − cash | $178M | $1.4B | $1.50T | $556.8B | $96.4B |
| Trailing P/EPrice ÷ TTM EPS | 25.89x | 30.58x | 16.00x | 14.66x | 32.17x |
| Forward P/EPrice ÷ next-FY EPS est. | 10.98x | 14.27x | 14.40x | 12.56x | 22.72x |
| PEG RatioP/E ÷ EPS growth rate | — | — | 0.90x | 0.95x | 2.85x |
| EV / EBITDAEnterprise value multiple | 12.88x | 14.03x | 18.36x | 13.92x | 19.40x |
| Price / SalesMarket cap ÷ Revenue | 0.53x | 0.84x | 3.20x | 2.21x | 2.71x |
| Price / BookPrice ÷ Book value/share | 1.06x | 1.75x | 2.47x | 1.39x | 6.82x |
| Price / FCFMarket cap ÷ FCF | 26.79x | 54.94x | 8.88x | 33.52x | 38.19x |
Profitability & Efficiency
CMI leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
CMI delivers a 20.3% return on equity — every $100 of shareholder capital generates $20 in annual profit, vs $3 for EML. EML carries lower financial leverage with a 0.43x debt-to-equity ratio, signaling a more conservative balance sheet compared to JPM's 2.60x. On the Piotroski fundamental quality scale (0–9), BAC scores 7/9 vs JPM's 5/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +3.1% | +3.8% | +15.9% | +10.1% | +20.3% |
| ROA (TTM)Return on assets | +1.7% | +2.0% | +1.3% | +0.9% | +7.8% |
| ROICReturn on invested capital | +4.5% | +6.2% | +4.5% | +3.5% | +16.1% |
| ROCEReturn on capital employed | +5.3% | +7.2% | +8.9% | +4.5% | +17.3% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 5 | 5 | 7 | 7 |
| Debt / EquityFinancial leverage | 0.43x | 0.47x | 2.60x | 1.21x | 0.61x |
| Net DebtTotal debt minus cash | $46M | $248M | $599.0B | $134.1B | $5.3B |
| Cash & Equiv.Liquid assets | $7M | $72M | $343.3B | $231.8B | $2.8B |
| Total DebtShort + long-term debt | $54M | $320M | $942.4B | $365.9B | $8.1B |
| Interest CoverageEBIT ÷ Interest expense | 2.90x | 5.48x | 0.74x | 0.48x | 12.15x |
Total Returns (Dividends Reinvested)
CMI leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CMI five years ago would be worth $27,921 today (with dividends reinvested), compared to $7,258 for EML. Over the past 12 months, CMI leads with a +105.6% total return vs EML's -6.1%. The 3-year compound annual growth rate (CAGR) favors CMI at 43.7% vs ASTE's 5.8% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +11.9% | +15.7% | -0.5% | +1.1% | +27.1% |
| 1-Year ReturnPast 12 months | -6.1% | +26.1% | +21.8% | +28.1% | +105.6% |
| 3-Year ReturnCumulative with dividends | +35.5% | +18.4% | +138.2% | +103.0% | +196.7% |
| 5-Year ReturnCumulative with dividends | -27.4% | -15.7% | +118.2% | +47.1% | +179.2% |
| 10-Year ReturnCumulative with dividends | +61.1% | +3.4% | +465.8% | +368.2% | +530.6% |
| CAGR (3Y)Annualised 3-year return | +10.7% | +5.8% | +33.6% | +26.6% | +43.7% |
Risk & Volatility
Evenly matched — EML and BAC each lead in 1 of 2 comparable metrics.
Risk & Volatility
EML is the less volatile stock with a 0.66 beta — it tends to amplify market swings less than CMI's 1.64 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. BAC currently trades 97.3% from its 52-week high vs ASTE's 78.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.66x | 1.55x | 0.94x | 0.86x | 1.64x |
| 52-Week HighHighest price in past year | $26.77 | $65.65 | $337.25 | $57.55 | $718.08 |
| 52-Week LowLowest price in past year | $17.61 | $36.43 | $262.71 | $43.66 | $307.90 |
| % of 52W HighCurrent price vs 52-week peak | +81.2% | +78.2% | +95.1% | +97.3% | +91.9% |
| RSI (14)Momentum oscillator 0–100 | 43.9 | 45.2 | 59.1 | 68.3 | 49.0 |
| Avg Volume (50D)Average daily shares traded | 16K | 197K | 7.0M | 31.7M | 759K |
Analyst Outlook
Evenly matched — BAC and CMI each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: ASTE as "Buy", JPM as "Buy", BAC as "Buy", CMI as "Buy". Consensus price targets imply 10.4% upside for CMI (target: $728) vs -29.9% for ASTE (target: $36). For income investors, BAC offers the higher dividend yield at 2.26% vs ASTE's 1.00%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | — | $36.00 | $339.75 | $61.13 | $727.91 |
| # AnalystsCovering analysts | — | 12 | 61 | 54 | 51 |
| Dividend YieldAnnual dividend ÷ price | +2.0% | +1.0% | +1.9% | +2.3% | +1.2% |
| Dividend StreakConsecutive years of raises | 0 | 0 | 15 | 12 | 20 |
| Dividend / ShareAnnual DPS | $0.44 | $0.51 | $5.95 | $1.27 | $7.61 |
| Buyback YieldShare repurchases ÷ mkt cap | +2.8% | 0.0% | +3.9% | +5.1% | 0.0% |
CMI leads in 2 of 6 categories (Profitability & Efficiency, Total Returns). JPM leads in 1 (Income & Cash Flow). 2 tied.
EML vs ASTE vs JPM vs BAC vs CMI: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is EML or ASTE or JPM or BAC or CMI a better buy right now?
For growth investors, Astec Industries, Inc.
(ASTE) is the stronger pick with 8. 1% revenue growth year-over-year, versus -8. 7% for The Eastern Company (EML). Bank of America Corporation (BAC) offers the better valuation at 14. 7x trailing P/E (12. 6x forward), making it the more compelling value choice. Analysts rate Astec Industries, Inc. (ASTE) a "Buy" — based on 12 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — EML or ASTE or JPM or BAC or CMI?
On trailing P/E, Bank of America Corporation (BAC) is the cheapest at 14.
7x versus Cummins Inc. at 32. 2x. On forward P/E, The Eastern Company is actually cheaper at 11. 0x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: JPMorgan Chase & Co. wins at 0. 81x versus Cummins Inc. 's 2. 01x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — EML or ASTE or JPM or BAC or CMI?
Over the past 5 years, Cummins Inc.
(CMI) delivered a total return of +179. 2%, compared to -27. 4% for The Eastern Company (EML). Over 10 years, the gap is even starker: CMI returned +530. 6% versus ASTE's +3. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — EML or ASTE or JPM or BAC or CMI?
By beta (market sensitivity over 5 years), The Eastern Company (EML) is the lower-risk stock at 0.
66β versus Cummins Inc. 's 1. 64β — meaning CMI is approximately 150% more volatile than EML relative to the S&P 500. On balance sheet safety, The Eastern Company (EML) carries a lower debt/equity ratio of 43% versus 3% for JPMorgan Chase & Co. — giving it more financial flexibility in a downturn.
05Which is growing faster — EML or ASTE or JPM or BAC or CMI?
By revenue growth (latest reported year), Astec Industries, Inc.
(ASTE) is pulling ahead at 8. 1% versus -8. 7% for The Eastern Company (EML). On earnings-per-share growth, the picture is similar: Astec Industries, Inc. grew EPS 784. 2% year-over-year, compared to -27. 7% for Cummins Inc.. Over a 3-year CAGR, CMI leads at 6. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — EML or ASTE or JPM or BAC or CMI?
JPMorgan Chase & Co.
(JPM) is the more profitable company, earning 20. 4% net margin versus 2. 1% for The Eastern Company — meaning it keeps 20. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: JPM leads at 26. 0% versus 4. 1% for EML. At the gross margin level — before operating expenses — JPM leads at 59. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is EML or ASTE or JPM or BAC or CMI more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, JPMorgan Chase & Co. (JPM) is the more undervalued stock at a PEG of 0. 81x versus Cummins Inc. 's 2. 01x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, The Eastern Company (EML) trades at 11. 0x forward P/E versus 22. 7x for Cummins Inc. — 11. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CMI: 10. 4% to $727. 91.
08Which pays a better dividend — EML or ASTE or JPM or BAC or CMI?
All stocks in this comparison pay dividends.
Bank of America Corporation (BAC) offers the highest yield at 2. 3%, versus 1. 0% for Astec Industries, Inc. (ASTE).
09Is EML or ASTE or JPM or BAC or CMI better for a retirement portfolio?
For long-horizon retirement investors, Bank of America Corporation (BAC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
86), 2. 3% yield, +368. 2% 10Y return). Astec Industries, Inc. (ASTE) carries a higher beta of 1. 55 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (BAC: +368. 2%, ASTE: +3. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between EML and ASTE and JPM and BAC and CMI?
These companies operate in different sectors (EML (Industrials) and ASTE (Industrials) and JPM (Financial Services) and BAC (Financial Services) and CMI (Industrials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: EML is a small-cap quality compounder stock; ASTE is a small-cap quality compounder stock; JPM is a large-cap deep-value stock; BAC is a large-cap deep-value stock; CMI is a mid-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.